Vandana Singh
·
March 27, 2025
Benzinga
Genmab's Tivdak wins Japan's approval for advanced cervical cancer after a Phase 3 trial showed improved survival over chemotherapy.
read more
April 11, 2025
March 11, 2025
February 28, 2025
December 6, 2024
Fortune